We are live on
!
Find out more
Pacific Biosciences
PACB
PACB
141 hedge funds and large institutions have $432M invested in Pacific Biosciences in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
159% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 27
93% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 15
9% more funds holding
Funds holding: 129 → 141 (+12)
11% less capital invested
Capital invested by funds: $487M → $432M (-$54.8M)
28% less call options, than puts
Call options by funds: $4.08M | Put options by funds: $5.66M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
141
Holders Change
+12
Holders Change %
+9.3%
% of All Funds
3.76%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
29
Increased
70
Reduced
27
Closed
15
Calls
$4.08M
Puts
$5.66M
Net Calls
-$1.58M
Net Calls Change
-$876K
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.9M |
| 2 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$15.9M |
| 3 |
BM
Bridger Management
New York
|
+$9.91M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$8.15M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$8.04M |
